Primary Therapy of Waldenström Macroglobulinemia With Bortezomib, Dexamethasone, and Rituximab: WMCTG Clinical Trial 05-180
AUTOR(ES)
Treon, Steven P.
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2727288Documentos Relacionados
- Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
- Waldenström's Macroglobulinemia
- Treatment of Waldenström's macroglobulinemia with alpha interferon.
- Penile ulcer as a specific clinical manifestation of Waldenstrom’s macroglobulinemia
- Macroglobulinemia de Waldenström - uma revisão